BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 12798881)

  • 21. Neuropsychological effects of methyltestosterone in women using menopausal hormone replacement.
    Regestein QR; Friebely J; Shifren J; Schiff I
    J Womens Health Gend Based Med; 2001 Sep; 10(7):671-6. PubMed ID: 11571096
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Testosterone patch for low sexual desire in surgically menopausal women: a randomized trial.
    Buster JE; Kingsberg SA; Aguirre O; Brown C; Breaux JG; Buch A; Rodenberg CA; Wekselman K; Casson P
    Obstet Gynecol; 2005 May; 105(5 Pt 1):944-52. PubMed ID: 15863529
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Esterified estrogens combined with methyltestosterone improve emotional well-being in postmenopausal women with chest pain and normal coronary angiograms.
    Adamson DL; Webb CM; Collins P
    Menopause; 2001; 8(4):233-8. PubMed ID: 11449079
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Evaluation of the clinical relevance of benefits associated with transdermal testosterone treatment in postmenopausal women with hypoactive sexual desire disorder.
    Kingsberg S; Shifren J; Wekselman K; Rodenberg C; Koochaki P; Derogatis L
    J Sex Med; 2007 Jul; 4(4 Pt 1):1001-8. PubMed ID: 17627745
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effects of the addition of methyltestosterone to combined hormone therapy with estrogens and progestogens on sexual energy and on orgasm in postmenopausal women.
    Penteado SR; Fonseca AM; Bagnoli VR; Abdo CH; Júnior JM; Baracat EC
    Climacteric; 2008 Feb; 11(1):17-25. PubMed ID: 18202961
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Efficacy and safety of a testosterone patch for the treatment of hypoactive sexual desire disorder in surgically menopausal women: a randomized, placebo-controlled trial.
    Davis SR; van der Mooren MJ; van Lunsen RH; Lopes P; Ribot C; Rees M; Moufarege A; Rodenberg C; Buch A; Purdie DW
    Menopause; 2006; 13(3):387-96. PubMed ID: 16735935
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Efficacy of vaginally applied estrogen, testosterone, or polyacrylic acid on sexual function in postmenopausal women: a randomized controlled trial.
    Fernandes T; Costa-Paiva LH; Pinto-Neto AM
    J Sex Med; 2014 May; 11(5):1262-70. PubMed ID: 24612478
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Relation of androgen receptor sensitivity and mood to sexual desire in hormonal contraception users.
    Elaut E; Buysse A; De Sutter P; De Cuypere G; Gerris J; Deschepper E; T'Sjoen G
    Contraception; 2012 May; 85(5):470-9. PubMed ID: 22133661
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Influence of methyltestosterone postmenopausal therapy on plasma lipids, inflammatory factors, glucose metabolism and visceral fat: a randomized study.
    Leão LM; Duarte MP; Silva DM; Bahia PR; Coeli CM; de Farias ML
    Eur J Endocrinol; 2006 Jan; 154(1):131-9. PubMed ID: 16382002
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Esterified estrogens with and without methyltestosterone decrease arterial LDL metabolism in cynomolgus monkeys.
    Wagner JD; Zhang L; Williams JK; Register TC; Ackerman DM; Wiita B; Clarkson TB; Adams MR
    Arterioscler Thromb Vasc Biol; 1996 Dec; 16(12):1473-80. PubMed ID: 8977451
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Comparison of androgens in women with hypoactive sexual desire disorder: those on combined oral contraceptives (COCs) vs. those not on COCs.
    Warnock JK; Clayton A; Croft H; Segraves R; Biggs FC
    J Sex Med; 2006 Sep; 3(5):878-882. PubMed ID: 16942531
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Preliminary clinical experience with androgen administration for pre- and postmenopausal women with hypoactive sexual desire.
    van Anders SM; Chernick AB; Chernick BA; Hampson E; Fisher WA
    J Sex Marital Ther; 2005; 31(3):173-85. PubMed ID: 16020137
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effects of transdermal testosterone or oral dydrogesterone on hypoactive sexual desire disorder in transsexual women: results of a pilot study.
    Kronawitter D; Gooren LJ; Zollver H; Oppelt PG; Beckmann MW; Dittrich R; Mueller A
    Eur J Endocrinol; 2009 Aug; 161(2):363-8. PubMed ID: 19497984
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Ovarian hormones and vaginal blood flow: using laser Doppler velocimetry to measure effects in a clinical trial of post-menopausal women.
    Sarrel PM
    Int J Impot Res; 1998 May; 10 Suppl 2():S91-3; discussion S98-101. PubMed ID: 9647968
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Transdermal testosterone treatment in women with impaired sexual function after oophorectomy.
    Shifren JL; Braunstein GD; Simon JA; Casson PR; Buster JE; Redmond GP; Burki RE; Ginsburg ES; Rosen RC; Leiblum SR; Caramelli KE; Mazer NA
    N Engl J Med; 2000 Sep; 343(10):682-8. PubMed ID: 10974131
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Variability of serum estrogens among postmenopausal women treated with the same transdermal estrogen therapy and the effect on androgens and sex hormone binding globulin.
    Kraemer GR; Kraemer RR; Ogden BW; Kilpatrick RE; Gimpel TL; Castracane VD
    Fertil Steril; 2003 Mar; 79(3):534-42. PubMed ID: 12620436
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Comparative effects of conventional hormone replacement therapy and tibolone on climacteric symptoms and sexual dysfunction in postmenopausal women.
    Ziaei S; Moghasemi M; Faghihzadeh S
    Climacteric; 2010 Apr; 13(2):147-56. PubMed ID: 19731119
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Efficacy of Tribulus terrestris for the treatment of hypoactive sexual desire disorder in postmenopausal women: a randomized, double-blinded, placebo-controlled trial.
    de Souza KZ; Vale FB; Geber S
    Menopause; 2016 Nov; 23(11):1252-1256. PubMed ID: 27760089
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effects of estrogen, androgen, and progestin on sexual psychophysiology and behavior in postmenopausal women.
    Myers LS; Dixen J; Morrissette D; Carmichael M; Davidson JM
    J Clin Endocrinol Metab; 1990 Apr; 70(4):1124-31. PubMed ID: 1690746
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Safety surveillance of esterified estrogens-methyltestosterone (Estratest and Estratest HS) replacement therapy in the United States.
    Phillips E; Bauman C
    Clin Ther; 1997; 19(5):1070-84. PubMed ID: 9385494
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.